Advertisement

Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 (HER2) Fluorescent In Situ Hybridization (FISH) Testing Increase HER2 Positive and HER2 Equivocal Breast Cancer Cases; Retrospective Study of HER2 FISH Results of 836 Invasive Breast Cancers

The aim of this study is to assess the impact of 2013 HER2 FISH testing guideline recommendations update on the assignment of HER2 status with dual probe HER2 FISH assay.

 Breast Cancer Research and Treatment

click me